Comparison of Gait Metrics in Patients With Stroke, Traumatic Brain Injury, and Multiple Sclerosis

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorCasa Colina Hospital and Centers for Healthcare

About this trial

People with neurological conditions often have difficulty walking, including problems such as foot drop. Functional electrical stimulation (FES) is a treatment that uses electrical signals to activate muscles and support walking. The L300 device is designed to help lift the foot during each step.

This study will evaluate how using the L300 affects walking performance. Researchers will measure walking speed, step length, and walking symmetry using objective gait assessment tools. The study will also explore whether people with different neurological conditions respond differently to FES.

The goal of this research is to improve understanding of how FES influences walking and to support more personalized rehabilitation approaches.

Eligibility criteria

Qualifiers

Adults aged 18-80 years.

Diagnosis of stroke, traumatic brain injury, or multiple sclerosis confirmed by medical records.

Presence of foot drop or impaired ankle dorsiflexion during gait.

Ability to ambulate at least 10 meters with or without assistive devices.

Disqualifiers

Severe lower limb contractures or orthopedic conditions that limit gait.

Implanted electrical devices (e.g., pacemaker) contraindicating FES use.

Uncontrolled medical conditions (e.g., severe cardiac disease).

Pregnancy.

Trial design

Treatments tested in this trial

  • Functional Electrical Stimulation
  • Normal care

Treatment groups

90 Participants
are divided into 2 treatment groups